Related Experiment Videos
[Obstetrical management of Streptococcus agalactiae]
R Quentin1, V Morange-Saussier, S Watt
1Département de Gynécologie, Obstétrique et Pathologie de la Reproduction, CHU Bretonneau, 37044 Tours Cedex 1, France.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|November 27, 2002
Summary
Screening pregnant women for Streptococcus agalactiae (S. agalactiae) carriage and administering penicillin during delivery is the best strategy. This prevents serious maternal and neonatal infections caused by S. agalactiae.
Area of Science:
- Microbiology
- Infectious Diseases
- Obstetrics & Gynecology
Context:
- Streptococcus agalactiae (S. agalactiae) is a primary cause of maternal and neonatal infections.
- Early detection and treatment are crucial for managing S. agalactiae infections.
Purpose:
- To evaluate the efficacy of screening for S. agalactiae vaginal carriage in pregnant women.
- To determine the optimal strategy for preventing S. agalactiae transmission to neonates.
Summary:
- Bacteriological examination of pregnant women and neonates with risk factors enables timely antibiotherapy.
- Screening for S. agalactiae vaginal carriage between 34-38 weeks of gestation is recommended.
- Penicillin administration during delivery is identified as the most effective preventive measure for asymptomatic carriers.
Impact:
- Implementation of this screening and treatment protocol can significantly reduce maternal and neonatal S. agalactiae infections.
- Early detection and intervention improve patient outcomes and decrease the incidence of severe infections.
- Establishes a best practice for preventing Group B Strep infections in newborns.